Skip to content

The effect of clomiphene citrate on clinical outcome in Progestin-Primed Ovarian Stimulation in normalovulatory women

The effect of clomiphene citrate on clinical outcome in Progestin-Primed Ovarian Stimulation in normalovulatory women

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-15006521
Enrollment
Unknown
Registered
2015-06-01
Start date
2015-05-20
Completion date
Unknown
Last updated
2017-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility

Interventions

HMG+MPA+CC:HMG+MPA+CC

Sponsors

The Shanghai Ninth People's Hospital affiliated of
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
22 Years to 40 Years

Inclusion criteria

Inclusion criteria: According to the WHO standards, the diagnosis of infertility; B-FSH less than 10IU/L; Age younger than 40 years; Normal menstrual cycle:24-35 days;Antral follicle counts more than 5; Did not receive any reproductive hormone drugs for nearly three months.

Exclusion criteria

Exclusion criteria: PCOS, endometrosis grade 3 or higher, documented ovarian failure, and any contraindications to ovarian stimulation treatment.

Design outcomes

Primary

MeasureTime frame
the number of oocyte retrieved;Rate of profound pituitary sppression;

Secondary

MeasureTime frame
LH value;Progesterone value;HMG consumption per oocyte retrieval;number of viable embryos;incidence of premeture LH;

Countries

China

Contacts

Public ContactKuang Yanping

Shanghai Nineth people's hospital

kuangyanp@126.com+86 021-53078108

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026